Latest news
Craig-Hallum Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $10 - MoomooMoomoo · Fri, 07 Aug 2026 07:54:52 GMTAclaris Therapeutics: Buy Rating Reiterated on Differentiated Pipeline and Extended Runway; $13 Price Target Maintained - TipRanksTipRanks · Thu, 06 Aug 2026 23:02:55 GMT